%0 Journal Article
%K Implementation
%K Compliance
%K Evidence-Based Practice
%K Treatment
%K Leishmaniasis
%B JBI Evidence Implementation
%D 2024
%I Ovid Technologies (Wolters Kluwer Health)
%R 10.1097/xeb.0000000000000416
%T Promoting safe and appropriate use of miltefosine to treat tegumentary leishmaniasis in Brazil: A best practice quality improvement project